U.S. IT Stock News

Voya Financial recently declared semi-annual and quarterly dividends on its Series A and Series B preferred shares, affirmed a US$0.47 common dividend for first-quarter 2026, and outlined additional share repurchases alongside a new sports partnership with Boston Legacy FC. These capital return decisions, combined with upcoming earnings and executive participation at a UBS investor conference, highlight how Voya is actively engaging shareholders while maintaining a visible presence in the...

In recent weeks, Edwards Lifesciences has drawn attention after exiting its planned JenaValve acquisition, raising 2026 EPS guidance, and emphasizing growth in its Transcatheter Aortic Valve Replacement (TAVR) and mitral platforms amid robust demand for structural heart procedures. An interesting angle for investors is how analysts’ upgraded views have clustered around the same theme: TAVR now anchors the company’s long-term focus, with internal platforms prioritized over external...

In January 2026, Murphy Oil Corporation reported fourth-quarter 2025 revenue of US$624.56 million and net income of US$11.89 million, alongside full-year revenue of US$2.72 billion and net income of US$104.23 million, both lower than the prior year despite steady production levels. At the same time, Murphy Oil raised its quarterly dividend to US$0.35 per share, issued US$500.00 million of 6.500% notes due 2034 to refinance existing debt, and outlined 2026 production guidance that gives...

If you are wondering whether Super Micro Computer's share price still reflects its true worth, you are not alone, many investors are asking the same question. The stock is roughly flat year to date with a 3.9% decline, and it has a modest 2.1% return over the past year but a very large gain over the past 5 years, close to 8x. Recent coverage has focused on Super Micro Computer's role in high performance computing and data center hardware, with attention on how its server platforms are...

New Jersey Resources Q1 2026 Earnings Snapshot New Jersey Resources (NJR) opened fiscal 2026 with Q1 revenue of US$604.9 million and basic EPS of US$1.22, setting a clear benchmark against its recent trading price of US$51.81. The company has seen quarterly revenue move from US$488.4 million in Q1 2025 to US$604.9 million in Q1 2026, while basic EPS shifted from US$1.32 to US$1.22 over the same periods. This gives investors a straightforward read on how the top and bottom lines compare with...

Broadridge Financial Solutions (BR) has put up another solid scorecard for Q2 2026, with revenue at US$1.6b and basic EPS at US$1.41 setting the tone for its latest update. The company has seen revenue move from US$1.59b in Q2 2025 to US$1.6b this quarter, while basic EPS shifted from US$1.22 to US$1.41 over the same period, alongside trailing 12 month EPS of US$7.90 and net income of US$925.1m that sit against a higher net margin than a year ago. Taken together, these earnings and margin...

Why Snap’s upcoming earnings matter for investors Snap (SNAP) is back in focus as it prepares to report earnings this Wednesday after the bell, with attention on user trends, digital ad demand, and early traction in newer revenue streams. See our latest analysis for Snap. Despite interest in its AI, AR and Snapchat+ efforts ahead of earnings, Snap’s recent share price performance has been weak, with a 30 day share price return of negative 25% and a 1 year total shareholder return of negative...

Madison Square Garden Entertainment (MSGE) has posted another mixed quarter, with Q2 2026 revenue of US$158.3 million and a basic EPS loss of US$0.46 framing the headline numbers. The company’s quarterly revenue has moved from US$138.7 million in Q1 2025 to US$407.4 million in Q2 2025, then to US$242.5 million in Q3 2025 and US$154.1 million in Q4 2025. Over the same period, basic EPS has ranged from a loss of US$0.40 in Q1 2025 to a profit of US$1.57 in Q2 2025, US$0.17 in Q3 2025 and a loss...

National Research (NRC) just posted its FY 2025 Q3 numbers, with revenue of US$34.6 million and EPS of US$0.18 setting the tone for a year that also includes a Q2 loss alongside a stronger Q1. Over recent quarters the company has seen revenue move from US$35.8 million in Q3 2024 to US$36.9 million in Q4 2024, then to US$33.6 million in Q1 2025 and US$34.0 million in Q2 2025. Over the same period, quarterly EPS shifted from US$0.24 to US$0.28, then US$0.25 before dipping slightly negative in...

Patria Investments (NasdaqGS:PAX) has reported third quarter FY 2025 results with revenue of US$86.5 million and basic EPS of US$0.14, setting the tone for a year where trailing 12 month revenue sits at US$405.8 million and EPS at US$0.67. The company has seen quarterly revenue run from US$74.9 million in Q2 2024 to US$86.5 million in Q3 2025, while basic EPS over that stretch has moved between roughly US$0.00 and US$0.35 per quarter, backed by trailing 12 month net income of US$106.3 million...

Capri Holdings (CPRI) has just posted its Q3 2026 numbers, with quarterly revenue of US$856 million and a basic EPS loss of US$0.28, alongside trailing 12 month EPS of US$10.14 in losses on US$4.4 billion of revenue. Over recent periods the company has seen revenue move between US$848 million and US$1.3 billion per quarter while EPS has swung from a profit of US$0.47 to losses of more than US$5 per share, setting a wide range for earnings outcomes that keeps the focus firmly on...

Hasbro (NasdaqGS:HAS) has announced new entertainment licensing deals tied to the upcoming live action Street Fighter movie and Netflix's KPop Demon Hunters. The company is rolling out associated merchandise, collectibles, and games, alongside a MY LITTLE PONY "Chase the Magic" collaborative sweepstakes that lets fans help shape a new character. These moves reflect a focus on fan engagement and franchise based products across films, streaming content, and long running toy brands. Hasbro,...

What triggered the latest move in MoonLake Immunotherapeutics MoonLake Immunotherapeutics (MLTX) has come into focus after a mix of analyst calls and an FDA update on its lead drug, sonelokimab, highlighted contrasting views on the company’s clinical and regulatory outlook. Goldman Sachs cut its rating, citing approval risk following the VELA-2 outcome in hidradenitis suppurativa, while the FDA granted Fast Track status for sonelokimab in palmoplantar pustulosis, supported by Phase 2 LEDA...

First Financial (THFF) just posted its FY 2025 third quarter numbers, with total revenue of US$69.3 million and basic EPS of US$1.75 setting the tone for its latest update. The company has seen quarterly revenue move from US$48.99 million in Q2 FY 2024 to US$69.3 million in Q3 FY 2025, while basic EPS has shifted from US$0.74 to US$1.75 over the same stretch, giving investors a clear view of how the income line has tracked alongside the top line. With a trailing twelve month net profit margin...

Heartland Express (HTLD) has opened FY 2025 with another tough quarter, reporting Q3 revenue of US$196.5 million and a basic EPS loss of US$0.11, alongside a trailing 12 month net loss of US$34.9 million on US$868.9 million of revenue. The company has seen quarterly revenue move from US$274.8 million in Q2 2024 to US$259.9 million in Q3 2024, then to US$242.6 million in Q4 2024 and US$219.4 million in Q1 2025, before landing at US$210.4 million in Q2 2025 and US$196.5 million in Q3 2025, with...

PJT Partners (PJT) has put up another busy quarter, with Q3 FY 2025 revenue of US$446.9 million and basic EPS of US$1.55, alongside trailing 12 month EPS of US$6.95 on revenue of about US$1.66 billion and TTM earnings growth of 64.9% year over year. Over recent periods the firm has seen quarterly revenue move from US$326.1 million in Q3 2024 to US$478.6 million in Q4 2024, then to US$324.3 million in Q1 2025, US$406.7 million in Q2 2025 and US$446.9 million in Q3 2025, with EPS shifting from...

Wondering whether Alvotech at US$5.32 is a bargain or a value trap? This article walks you through what the current price may be implying about the company. The stock has had a mixed run, with a 6.4% gain over the past month but a 57.0% loss over the last year and a 58.4% loss over three years, which can change how the market views its growth potential and risk. Recent coverage around Alvotech has focused on its position in biosimilars and its progress in bringing products to market, which...

Marzetti (MZTI) has just posted another quarter of solid headline numbers, with Q2 2026 revenue of US$493.5 million and basic EPS of US$1.71, backed by trailing twelve month EPS of US$6.17 on US$1.94 billion in revenue. The company has seen revenue move from US$466.6 million in Q1 2025 to US$509.3 million in Q2 2025 and US$493.5 million in Q1 2026, while quarterly EPS has ranged between US$1.18 and US$1.78 over that span. This points to earnings power that aligns with an 8.7% net margin...

In January, Needham analyst John Todaro reiterated his positive view on TeraWulf as the company shifts from traditional bitcoin mining toward high-performance computing and AI infrastructure, underpinned by contracted IT load and expansion plans. At the same time, Nvidia’s multibillion-dollar commitment to AI-focused cloud provider CoreWeave and TeraWulf’s partnerships with Fluidstack and Google highlighted how its repurposed industrial sites and planned 168-MW Texas facility link the...

Installed Building Products (NYSE:IBP) has acquired Thermo-Tech Mechanical Insulation, Biomax Spray Foam Insulation, and CKV Finished Products LLC. The transactions expand IBP's national footprint and broaden its mix across mechanical insulation, spray foam, and finishing services. These moves add to IBP's presence in both residential and commercial construction markets and increase operational diversification. Installed Building Products, listed on the NYSE under the ticker IBP, focuses on...

MPLX (MPLX) has turned in a solid set of FY 2025 numbers, with Q3 revenue of US$2,949 million and basic EPS of US$1.52 anchoring a trailing twelve month EPS of US$4.72 on revenue of US$11.6 billion. The company has seen quarterly revenue range between US$2,707 million and US$2,949 million from Q2 2024 through Q3 2025, while basic EPS has moved between US$1.01 and US$1.52 over the same stretch. This gives investors a clear view of how earnings are tracking against a steady top line. With net...

Century Communities: recent performance snapshot Century Communities (CCS) has drawn fresh attention after recent trading, with the share price at $65.64 and returns of 4.2% over the past week and 11.4% over the past month. Investors are weighing that short term move against a 12.5% negative 1 year total return and longer term total returns of 6.6% over 3 years and 17.9% over 5 years. See our latest analysis for Century Communities. The recent 1 month share price return of 11.37% at a share...

T. Rowe Price Group (NasdaqGS:TROW) announced a planned leadership transition at T. Rowe Price Investment Management as Steph Jackson retires and Steven Krichbaum takes over. The firm also introduced the T. Rowe Price Innovation Leaders ETF, expanding its ETF lineup with an actively managed strategy focused on innovation themes. These updates arrive while the company’s shares trade around $102.66 and follow a multiyear period of mixed total return performance. T. Rowe Price Group, trading...

Booking Holdings (BKNG) has put leadership changes at KAYAK front and center, naming longtime finance and operations executive Peer Bueller as CEO, while co founder Steve Hafner becomes Executive Chair and shifts toward an AI focused role at the group. See our latest analysis for Booking Holdings. The leadership changes at KAYAK come as Booking Holdings’ share price has pulled back, with a 1 month share price return of 12.75% decline and a year to date share price return of 12.75% decline,...